Taisho Pharmaceutical Holdings Co., Ltd. (TSE:4581) entered into an agreement to acquire Bonviva Business from Chugai Pharmaceutical Co., Ltd. and F. Hoffmann-La Roche on November 24, 2022. The closing of the transaction is expected to take place after certain conditions including approvals from relevant authorities are fulfilled.